SITC Guidelines Provide a Fresh Look at Evolving Strategies for Melanoma

Source: OncLive, April 2019

Researchers have announced a study to identify new treatments that could improve survival rates for an uveal melanoma, a form of eye cancer.

Fight for Sight said researchers from the University of Liverpool will be analysing tumour samples to gain a better understanding about the role of mutation in a gene known as BAP1 in the development of uveal melanoma.

The underlying changes that result from mutation of this gene will then be targeted with drugs that could improve survival rates for patients.

read the original full article